Resveratrol and miR-200c: insights into the prevention of oral squamous cell carcinoma.

Future Oncol

Division of Oral Pathology, Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan, 45142, Saudi Arabia.

Published: October 2022

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2022-0672DOI Listing

Publication Analysis

Top Keywords

resveratrol mir-200c
4
mir-200c insights
4
insights prevention
4
prevention oral
4
oral squamous
4
squamous cell
4
cell carcinoma
4
resveratrol
1
insights
1
prevention
1

Similar Publications

Resveratrol and miR-200c: insights into the prevention of oral squamous cell carcinoma.

Future Oncol

October 2022

Division of Oral Pathology, Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan, 45142, Saudi Arabia.

View Article and Find Full Text PDF

Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.

Hum Reprod Update

January 2018

Department of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica delle Marche, via Tronto 10/a, Ancona 60020, Italy.

Background: Uterine leiomyoma (also known as fibroid or myoma) is the most common benign tumor of the uterus found in women of reproductive age. It is not usually fatal but can produce serious clinical symptoms, including excessive uterine bleeding, pelvic pain or pressure, infertility and pregnancy complications. Due to lack of effective medical treatments surgery has been a definitive choice for the management of this tumor.

View Article and Find Full Text PDF

Objective: colorectal cancer (CRC) is one of the most common malignancies, associated with high rates of relapse. A notable challenge in treatment is low response rate to current therapies for advanced CRC. The miR-200c plays an essential role in tumor suppression by inhibiting epithelial-mesenchymal transition (EMT).

View Article and Find Full Text PDF

Oral submucous fibrosis (OSF) is a precancerous condition of the oral mucosa without specific therapeutic drugs. We previously demonstrated that the zinc finger E-box binding homeobox 1 (ZEB1) plays a pathogenic role in the induction of the myofibroblast activity of buccal mucosal fibroblasts (BMFs) and contributes to the pathogenesis of OSF. Resveratrol is a natural polyphenolic flavonoid with anti-fibrosis activity in various tissues and has the capability to inhibit ZEB1 in oral cancer cells.

View Article and Find Full Text PDF

Breast cancer is the most frequently diagnosed cancer in women, and one of the leading causes of cancer-related deaths worldwide. Recent evidences indicate that dietary agents such as resveratrol may inhibit cancer progression through modulation of microRNAs (miRNAs). We demonstrate that resveratrol regulates apoptotic and cell cycle machinery in breast cancer cells by modulating key tumor-suppressive miRNAs including miR-125b-5p, miR-200c-3p, miR-409-3p, miR-122-5p and miR-542-3p.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!